Compare VCEL & UCTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCEL | UCTT |
|---|---|---|
| Founded | 1989 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1997 | 2004 |
| Metric | VCEL | UCTT |
|---|---|---|
| Price | $35.89 | $55.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $57.50 | $40.00 |
| AVG Volume (30 Days) | 417.8K | ★ 1.1M |
| Earning Date | 02-26-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 236.54 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | $258,716,999.00 | ★ $2,110,600,000.00 |
| Revenue This Year | $18.02 | N/A |
| Revenue Next Year | $18.52 | $5.74 |
| P/E Ratio | $145.81 | ★ N/A |
| Revenue Growth | ★ 14.05 | 6.65 |
| 52 Week Low | $29.24 | $16.66 |
| 52 Week High | $58.77 | $58.70 |
| Indicator | VCEL | UCTT |
|---|---|---|
| Relative Strength Index (RSI) | 42.11 | 68.74 |
| Support Level | $33.30 | $52.16 |
| Resistance Level | $36.56 | $58.70 |
| Average True Range (ATR) | 1.56 | 3.50 |
| MACD | -0.27 | 0.40 |
| Stochastic Oscillator | 28.50 | 74.15 |
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.